1. You, Z, Xu, L L, Li, X F, DU, J, Sun, L S. . [BRAF gene mutations in ameloblastic fibromas]. In Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences, 51, 4-8. doi:10.19723/j.issn.1671-167X.2019.01.002. https://pubmed.ncbi.nlm.nih.gov/30773536/
2. Afrăsânie, Vlad-Adrian, Marinca, Mihai Vasile, Alexa-Stratulat, Teodora, Miron, Lucian, Rusu, Cristina. 2019. KRAS, NRAS, BRAF, HER2 and microsatellite instability in metastatic colorectal cancer - practical implications for the clinician. In Radiology and oncology, 53, 265-274. doi:10.2478/raon-2019-0033. https://pubmed.ncbi.nlm.nih.gov/31553708/
3. Uhlitz, Florian, Bischoff, Philip, Peidli, Stefan, Blüthgen, Nils, Morkel, Markus. 2021. Mitogen-activated protein kinase activity drives cell trajectories in colorectal cancer. In EMBO molecular medicine, 13, e14123. doi:10.15252/emmm.202114123. https://pubmed.ncbi.nlm.nih.gov/34409732/
4. Huang, Dongdong, Sun, Wenjie, Zhou, Yuwei, Wu, Yihua, Zhang, Honghe. . Mutations of key driver genes in colorectal cancer progression and metastasis. In Cancer metastasis reviews, 37, 173-187. doi:10.1007/s10555-017-9726-5. https://pubmed.ncbi.nlm.nih.gov/29322354/
5. Li, Wei, Xu, Han, Xiao, Tengfei, Brown, Myles, Liu, X Shirley. . MAGeCK enables robust identification of essential genes from genome-scale CRISPR/Cas9 knockout screens. In Genome biology, 15, 554. doi:. https://pubmed.ncbi.nlm.nih.gov/25476604/
6. Tannapfel, A, Sommerer, F, Benicke, M, Hauss, J, Wittekind, C. . Mutations of the BRAF gene in cholangiocarcinoma but not in hepatocellular carcinoma. In Gut, 52, 706-12. doi:. https://pubmed.ncbi.nlm.nih.gov/12692057/
7. Kobayashi, Masashi, Sonobe, Makoto, Takahashi, Tsuyoshi, Huang, Cheng-Long, Date, Hiroshi. . Clinical significance of BRAF gene mutations in patients with non-small cell lung cancer. In Anticancer research, 31, 4619-23. doi:. https://pubmed.ncbi.nlm.nih.gov/22199339/
智鼠故事 
